CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 390830-391060 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T72093","span":{"begin":0,"end":230},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Further study is indicated to determine which patients with urticaria are most likely to benefit from pentoxifylline, as well as elucidate the mechanisms of action by which pentoxifylline ameliorates symptoms of chronic urticaria."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T716","span":{"begin":0,"end":230},"obj":"Epistemic_statement"}],"text":"Further study is indicated to determine which patients with urticaria are most likely to benefit from pentoxifylline, as well as elucidate the mechanisms of action by which pentoxifylline ameliorates symptoms of chronic urticaria."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T301","span":{"begin":0,"end":230},"obj":"Sentence"}],"text":"Further study is indicated to determine which patients with urticaria are most likely to benefit from pentoxifylline, as well as elucidate the mechanisms of action by which pentoxifylline ameliorates symptoms of chronic urticaria."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4011","span":{"begin":60,"end":69},"obj":"Disease"},{"id":"T4012","span":{"begin":220,"end":229},"obj":"Disease"}],"attributes":[{"id":"A4011","pred":"mondo_id","subj":"T4011","obj":"http://purl.obolibrary.org/obo/MONDO_0005492"},{"id":"A4012","pred":"mondo_id","subj":"T4012","obj":"http://purl.obolibrary.org/obo/MONDO_0005492"}],"text":"Further study is indicated to determine which patients with urticaria are most likely to benefit from pentoxifylline, as well as elucidate the mechanisms of action by which pentoxifylline ameliorates symptoms of chronic urticaria."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T2155","span":{"begin":60,"end":69},"obj":"Phenotype"},{"id":"T2156","span":{"begin":220,"end":229},"obj":"Phenotype"}],"attributes":[{"id":"A2155","pred":"hp_id","subj":"T2155","obj":"http://purl.obolibrary.org/obo/HP_0001025"},{"id":"A2156","pred":"hp_id","subj":"T2156","obj":"http://purl.obolibrary.org/obo/HP_0001025"}],"text":"Further study is indicated to determine which patients with urticaria are most likely to benefit from pentoxifylline, as well as elucidate the mechanisms of action by which pentoxifylline ameliorates symptoms of chronic urticaria."}